XML 17 R6.htm IDEA: XBRL DOCUMENT v3.22.2
CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY - USD ($)
$ in Millions
Total
Common stock:
Additional paid-in-capital:
Treasury stock at cost:
Retained earnings:
Accumulated other comprehensive income:
Beginning balance at Dec. 31, 2020   $ 2 $ 16,497 $ (36,515) $ 22,961 $ 616
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Common stock issued   0        
Common stock repurchased   0        
Common stock and stock-based awards issued     58      
Tax withholdings related to net share settlements of restricted stock units and awards     (128)      
Stock-based compensation     256      
Common stock repurchased     0 (1,793)    
Other     (7)      
Net income (loss) $ 11,375       11,375  
Dividends and dividend equivalents declared         (250)  
Foreign currency translation adjustment           (107)
Change in unrealized gains (losses) on investments (4)         (4)
Change in unrealized gains (losses) on derivative instruments           70
Tax benefit (provision) on above items           (15)
Ending balance at Jun. 30, 2021 $ 13,016 2 16,676 (38,308) 34,086 560
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Dividends and dividend equivalents declared per share or restricted stock unit (in usd per share) $ 0.36          
Beginning balance at Mar. 31, 2021   2 16,546 (36,807) 23,476 553
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Common stock issued   0        
Common stock repurchased   0        
Common stock and stock-based awards issued     57      
Tax withholdings related to net share settlements of restricted stock units and awards     (59)      
Stock-based compensation     140      
Common stock repurchased     0 (1,501)    
Other     (8)      
Net income (loss) $ 10,734       10,734  
Dividends and dividend equivalents declared         (124)  
Foreign currency translation adjustment           10
Change in unrealized gains (losses) on investments (1)         (1)
Change in unrealized gains (losses) on derivative instruments           (4)
Tax benefit (provision) on above items           2
Ending balance at Jun. 30, 2021 $ 13,016 2 16,676 (38,308) 34,086 560
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Dividends and dividend equivalents declared per share or restricted stock unit (in usd per share) $ 0.18          
Beginning balance at Dec. 31, 2021 $ 9,778 2 16,659 (43,371) 36,090 398
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Common stock issued   0        
Common stock repurchased   0        
Common stock and stock-based awards issued     55      
Tax withholdings related to net share settlements of restricted stock units and awards     (98)      
Stock-based compensation     248      
Common stock repurchased (2,542)   188 (2,730)    
Other     7      
Net income (loss) (1,872)       (1,872)  
Dividends and dividend equivalents declared         (258)  
Foreign currency translation adjustment           (119)
Change in unrealized gains (losses) on investments (68)         (68)
Change in unrealized gains (losses) on derivative instruments           125
Tax benefit (provision) on above items           (13)
Ending balance at Jun. 30, 2022 $ 5,243 2 17,059 (46,101) 33,960 323
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Dividends and dividend equivalents declared per share or restricted stock unit (in usd per share) $ 0.44          
Beginning balance at Mar. 31, 2022   2 16,904 (44,809) 34,615 342
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Common stock issued   0        
Common stock repurchased   0        
Common stock and stock-based awards issued     54      
Tax withholdings related to net share settlements of restricted stock units and awards     (37)      
Stock-based compensation     137      
Common stock repurchased     0 (1,292)    
Other     1      
Net income (loss) $ (531)       (531)  
Dividends and dividend equivalents declared         (124)  
Foreign currency translation adjustment           (85)
Change in unrealized gains (losses) on investments (17)         (17)
Change in unrealized gains (losses) on derivative instruments           105
Tax benefit (provision) on above items           (22)
Ending balance at Jun. 30, 2022 $ 5,243 $ 2 $ 17,059 $ (46,101) $ 33,960 $ 323
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Dividends and dividend equivalents declared per share or restricted stock unit (in usd per share) $ 0.22